The evolving role of the NAD+/nicotinamide metabolome in skin homeostasis, cellular bioenergetics, and aging

DNA Repair

Volumn 23, Issue , 2014, Pages 59-63

  Oblong, John E ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Aging; Cellular bioenergetics; Glycolysis; Mitochondria; NAD+; Nicotinamide; Oxidative phosphorylation; Oxidative stress; Photoaging; Skin

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 6; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIRTUIN; TUMOR NECROSIS FACTOR ALPHA; NICOTINAMIDE;

AGING; ARTICLE; BIOENERGY; CANCER PREVENTION; CELL METABOLISM; CIRCADIAN RHYTHM; DEACETYLATION; DNA REPAIR; ENZYME ACTIVITY; FEEDBACK SYSTEM; FIBROBLAST; GENE EXPRESSION; GENOMIC INSTABILITY; GLYCOLYSIS; HOMEOSTASIS; HUMAN; LONGEVITY; METABOLIC REGULATION; METABOLITE; METABOLOME; MITOCHONDRION; MITOPHAGY; NONHUMAN; OSCILLATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PHOTOAGING; PREMATURE AGING; RESPIRATORY CHAIN; ADVERSE EFFECTS; ENERGY METABOLISM; METABOLISM; PHYSIOLOGY; RADIATION RESPONSE; SKIN; ULTRAVIOLET RADIATION;

AGING; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; METABOLOME; NAD; NIACINAMIDE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; SKIN; ULTRAVIOLET RAYS;

EID: 84917730166     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.04.005     Document Type: Article

References (71)

1. Burke K.E., Wei H. Synergistic damage by UVA radiation and pollutants. Toxicol. Ind. Health 2009, 25:219-224.
2. Kligman L.H. Photoaging. Manifestations, prevention, and treatment. Dermatol. Clin. 1986, 4:517-528.
3. Gilchrest B.A. Skin aging and photoaging: an overview. J. Am. Acad. Dermatol. 1989, 21:610-613.
4. Matsumura Y., Ananthaswamy H.N. Short-term and long-term cellular and molecular events following UV irradiation of skin: implications for molecular medicine. Expert Rev. Mol. Med. 2002, 4:1-22.
5. Pacifici R.E., Davies K.J. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 1991, 37:166-180.
6. Kligman L.H., Kligman A.M. The nature of photoaging: its prevention and repair. Photodermatology 1986, 3:215-227.
7. Davis T., Kipling D. Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome?. Rejuvenation Res. 2006, 9:402-407.
8. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
9. Miyachi Y. Photoaging from an oxidative standpoint. J. Dermatol. Sci. 1995, 9:79-86.
10. Burke K.E. Photoaging: the role of oxidative stress. G. Ital. Dermatol. Venereol. 2010, 145:445-459.
11. Norval M., Halliday G.M. The consequences of UV-induced immunosuppression for human health. Photochem. Photobiol. 2011, 87:965-977.
12. Pfeifer G.P., Besaratinia A. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem. Photobiol. Sci. 2012, 11:90-97.
13. Bandy B., Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 1990, 8:523-539.
14. Jacobson E.L., Giacomoni P.U., Roberts M.J., Wondrak G.T., Jacobson M.K. Optimizing the energy status of skin cells during solar radiation. J. Photochem. Photobiol. B 2001, 63:141-147.
15. Ma Y.S., Wu S.B., Lee W.Y., Cheng J.S., Wei Y.H. Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim. Biophys. Acta 2009, 1790:1021-1029.
16. Galluzzi L., Kepp O., Trojel-Hansen C., Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ. Res. 2012, 111:1198-1207.
17. Brand M.D., Orr A.L., Perevoshchikova I.V., Quinlan C.L. The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br. J. Dermatol. 2013, 169(Suppl. 2):1-8.
18. Newgard C.B., Sharpless N.E. Coming of age: molecular drivers of aging and therapeutic opportunities. J. Clin. Invest. 2013, 123:946-950.
19. Birch-Machin M.A., Swalwell H. How mitochondria record the effects of UV exposure and oxidative stress using human skin as a model tissue. Mutagenesis 2010, 25:101-107.
20. Harman D. Free radical theory of aging. Mutat. Res. 1992, 275:257-266.
21. von Zglinicki T. A mitochondrial membrane hypothesis of aging. J. Theor. Biol. 1987, 127:127-132.
22. Tulah S.H., Birch-Machin M.A. Stressed out mitochondria: the role of mitochondria in ageing and cancer focussing on strategies and opportunities in human skin. Mitochondrion 2013, 13:444-453.
23. Birch-Machin M.A., Russell E.V., Latimer J.A. Mitochondrial DNA damage as a biomarker for ultraviolet radiation exposure and oxidative stress. Br. J. Dermatol. 2013, 169(Suppl. 2):9-14.
24. Greco M., Villani G., Mazzucchelli F., Bresolin N., Papa S., Attardi G. Marked aging-related decline in efficiency of oxidative phosphorylation in human skin fibroblasts. FASEB J. 2003, 17:1706-1708.
25. Krutmann J., Schroeder P. Role of mitochondria in photoaging of human skin: the defective powerhouse model. J. Investig. Dermatol. Symp. Proc. 2009, 14:44-49.
26. Wei Y.H., Wu S.B., Ma Y.S., Lee H.C. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med. J. 2009, 32:113-132.
27. Magni G., Amici A., Emanuelli M., Orsomando G., Raffaelli N., Ruggieri S. Enzymology of NAD+ homeostasis in man. Cell. Mol. Life Sci. 2004, 61:19-34.
28. Hageman G.J., Stierum R.H. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat. Res. 2001, 475:45-56.
29. Houtkooper R.H., Pirinen E., Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 2012, 13:225-238.
30. Sassone-Corsi P. Minireview: NAD+, a circadian metabolite with an epigenetic twist. Endocrinology 2012, 153:1-5.
31. Bellet M.M., Orozco-Solis R., Sahar S., Eckel-Mahan K., Sassone-Corsi P. The time of metabolism: NAD+, SIRT1, and the circadian clock. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:31-38.
32. Cantó C., Auwerx J. NAD+ as a signaling molecule modulating metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:291-298.
33. Gomes A.P., Price N.L., Ling A.J., Moslehi J.J., Montgomery M.K., Rajman L., White J.P., Teodoro J.S., Wrann C.D., Hubbard B.P., Mercken E.M., Palmeira C.M., de Cabo R., Rolo A.P., Turner N., Bell E.L., Sinclair D.A. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013, 155:1624-1638.
34. Mouchiroud L., Houtkooper R.H., Moullan N., Katsyuba E., Ryu D., Cantó C., Mottis A., Jo Y.S., Viswanathan M., Schoonjans K., Guarente L., Auwerx J. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013, 154:430-441.
35. Peek C.B., Affinati A.H., Ramsey K.M., Kuo H.Y., Yu W., Sena L.A., Ilkayeva O., Marcheva B., Kobayashi Y., Omura C., Levine D.C., Bacsik D.J., Gius D., Newgard C.B., Goetzman E., Chandel N.S., Denu J.M., Mrksich M., Bass J. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 2013, 342:1243417.
36. Imai S. Clocks in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim. Biophys. Acta 2010, 1804:1584-1590.
37. Nakahata Y., Kaluzova M., Grimaldi B., Sahar S., Hirayama J., Chen D., Guarente L.P., Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134:329-340.
38. Porcu M., Chiarugi A. The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol. Sci. 2005, 26:94-103.
39. Adams J.D., Klaidman L.K. Sirtuins, nicotinamide and aging: a critical review. Lett. Drug Des. Discov. 2007, 4:44-48.
40. Harris L.J. Nicotinamide and pellagra: a review of the development of knowledge and of the present position. Practitioner 1952, 168:57-59.
41. Williams A.C., Ramsden D.B. Pellagra: a clue as to why energy failure causes diseases?. Med. Hypotheses 2007, 69:618-628.
42. Niren N.M. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. Cutis 2006, 77:11-16.
43. Shahmoradi Z., Iraji F., Siadat A.H., Ghorbaini A. Comparison of topical 5% nicotinamide gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: a double-blinded randomized clinical trial. J. Res. Med. Sci. 2013, 18:115-117.
44. Tanno O., Ota Y., Kitamura N., Katsube T., Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br. J. Dermatol. 2000, 143:524-531.
45. Bissett D. Topical niacinamide and barrier enhancement. Cutis 2002, 70(6 Suppl.):8-12.
46. Bissett D.L., Oblong J.E., Berge C.A. Niacinamide: a B vitamin that improves aging facial skin appearance. Dermatol. Surg. 2005, 31:860-865.
47. Draelos Z.D., Matsubara A., Smiles K. The effect of 2% niacinamide on facial sebum production. J. Cosmet. Laser Ther. 2006, 8:96-101.
48. Damian D.L. Photoprotective effects of nicotinamide. Photochem. Photobiol. Sci. 2010, 9:578-585.
49. Surjana D., Damian D.L. Nicotinamide in dermatology and photoprotection. Skinmed 2011, 9:360-365.
50. Surjana D., Halliday G.M., Damian D.L. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis 2013, 34:1144-1149.
51. Monfrecola G., Gaudiello F., Cirillo T., Fabbrocini G., Balato A., Lembo S. Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation. Clin. Exp. Dermatol. 2013, 38:185-188. 10.1111/ced.12018.
52. Gensler H.L. Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutr. Cancer 1997, 29:157-162.
53. Damian D.L., Patterson C.R., Stapelberg M., Park J., Barnetson R.S., Halliday G.M. UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J. Invest. Dermatol. 2008, 128:447-454.
54. Yiasemides E., Sivapirabu G., Halliday G.M., Park J., Damian D.L. Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis 2009, 30:101-105.
55. Surjana D., Halliday G.M., Martin A.J., Moloney F.J., Damian D.L. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J. Invest. Dermatol. 2012, 132:1497-1500.
56. Maiese K., Chong Z.Z., Hou J., Shang Y.C. The vitamin nicotinamide: translating nutrition into clinical care. Molecules 2009, 14:3446-3485.
57. Stein L.R., Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol. Metab. 2012, 23:420-428.
58. Park J., Halliday G.M., Surjana D., Damian D.L. Nicotinamide prevents ultraviolet radiation-induced cellular energy loss. Photochem. Photobiol. 2010, 86:942-948.
59. Hasmann M., Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 2003, 63:7436-7442.
60. Rovito H.A., Oblong J.E. Nicotinamide preferentially protects glycolysis in dermal fibroblasts under oxidative stress conditions. Br. J. Dermatol. 2013, 169(Suppl. 2):15-24.
61. Pittelli M., Formentini L., Faraco G., Lapucci A., Rapizzi E., Cialdai F., Romano G., Moneti G., Moroni F., Chiarugi A. Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J. Biol. Chem. 2010, 285:34106-34114.
62. Nikiforov A., Dölle C., Niere M., Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 2011, 286:21767-21778.
63. Jang S.Y., Kang H.T., Hwang E.S. Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J. Biol. Chem. 2012, 287:19304-19314.
64. Jacobson E.L., Antol K.M., Juarez-Salinas H., Jacobson M.K. Poly(ADP-ribose) metabolism in ultraviolet irradiated human fibroblasts. J. Biol. Chem. 1983, 258:103-107.
65. Massudi H., Grant R., Braidy N., Guest J., Farnsworth B., Guillemin G.J. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One 2012, 7:e42357.
66. Balu M., Mazhar A., Hayakawa C.K., Mittal R., Krasieva T.B., König K., Venugopalan V., Tromberg B.J. In vivo multiphoton NADH fluorescence reveals depth-dependent keratinocyte metabolism in human skin. Biophys. J. 2013, 104:258-267.
67. Miyamoto K., Kudoh H. Quantification and visualization of cellular NAD(P)H in young and aged female facial skin with in vivo two-photon tomography. Br. J. Dermatol. 2013, 169(Suppl. 2):25-31.
68. Jacobson E.L., Kim H., Kim M., Williams J.D., Coyle D.L., Coyle W.R., Grove G., Rizer R.L., Stratton M.S., Jacobson M.K. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp. Dermatol. 2007, 16:490-499.
69. Sivapirabu G., Yiasemides E., Halliday G.M., Park J., Damian D.L. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br. J. Dermatol. 2009, 161:1357-1364.
70. Koch-Nolte F., Haag F., Guse A.H., Lund F., Ziegler M. Emerging roles of NAD+ and its metabolites in cell signaling. Sci. Signal. 2009, 2(57). mr1.
71. Magni G., Amici A., Emanuelli M., Raffaelli N., Ruggieri S. Enzymology of NAD+ synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 1999, 73:135-812.